A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease

doi:10.1016/j.pediatrneurol.2017.05.022

Review

. 2017 Sep:74:87-91.e2.

doi: 10.1016/j.pediatrneurol.2017.05.022. Epub 2017 Jun 1.

A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease

Rebecca Barmherzig¹, Garrett Bullivant², Dawn Cordeiro², David S Sinasac³, Susan Blaser⁴, Saadet Mercimek-Mahmutoglu⁵

Affiliations

¹ Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
² Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
³ Department of Medical Genetics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Alberta, Canada.
⁴ Division of Pediatric Neuroradiology, Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada; Diagnostic Neuroradiology, Department of Medical Imaging, University of Toronto, Toronto, Ontario Canada.
⁵ Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada; Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada; Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Pediatrics, University of Toronto, Toronto, Ontario Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario Canada. Electronic address: saadet.mahmutoglu@sickkids.ca.

PMID: 28662915
DOI: 10.1016/j.pediatrneurol.2017.05.022

Review

A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease

Rebecca Barmherzig et al. Pediatr Neurol. 2017 Sep.

. 2017 Sep:74:87-91.e2.

doi: 10.1016/j.pediatrneurol.2017.05.022. Epub 2017 Jun 1.

Authors

Rebecca Barmherzig¹, Garrett Bullivant², Dawn Cordeiro², David S Sinasac³, Susan Blaser⁴, Saadet Mercimek-Mahmutoglu⁵

Affiliations

¹ Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
² Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
³ Department of Medical Genetics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Alberta, Canada.
⁴ Division of Pediatric Neuroradiology, Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada; Diagnostic Neuroradiology, Department of Medical Imaging, University of Toronto, Toronto, Ontario Canada.
⁵ Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada; Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada; Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Pediatrics, University of Toronto, Toronto, Ontario Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario Canada. Electronic address: saadet.mahmutoglu@sickkids.ca.

PMID: 28662915
DOI: 10.1016/j.pediatrneurol.2017.05.022

Abstract

Background: Likely pathogenic variants in SLC17A5 results in allelic disorders of free sialic acid metabolism including (1) infantile free sialic acid storage disease with severe global developmental delay, coarse facial features, hepatosplenomegaly, and cardiomegaly; (2) intermediate severe Salla disease with moderate to severe global developmental delay, hypotonia, and hypomyelination with or without coarse facial features, and (3) Salla disease with normal appearance, mild cognitive dysfunction, and spasticity.

Patient description: This five-year-old girl presented with infantile-onset severe global developmental delay, truncal hypotonia, and generalized dystonia following normal development during her first six months of life. Brain magnetic resonance imaging showed marked hypomyelination and a thin corpus callosum at age 19 months, both unchanged on follow-up at age 28 months. Urine free sialic acid was moderately elevated. Cerebrospinal fluid free sialic acid was marginally elevated. Sequencing of SLC17A5 revealed compound heterozygous likely pathogenic variants, namely, a known missense (c.291G>A) variant and a novel truncating (c.819+1G>A) variant, confirming the diagnosis of Salla disease at age 3.5 years.

Conclusion: We report a new patient with intermediate severe Salla disease. Normal or marginally elevated urine or cerebrospinal fluid free sialic acid levels cannot exclude Salla disease. In patients with progressive global developmental delay and hypomyelination on brain magnetic resonance imaging, Salla disease should be included into the differential diagnosis.

Keywords: SLC17A5; Salla disease; free sialic acid; global developmental delay; hypomyelination.

PubMed Disclaimer

Comment in

First Patient With Salla Disease Confirmed by Genomic Analysis in Japan.
Matsuura R, Hamano SI, Iwamoto T, Shimizu K, Ohashi H. Matsuura R, et al. Pediatr Neurol. 2018 Apr;81:52-53. doi: 10.1016/j.pediatrneurol.2018.01.002. Epub 2018 Jan 31. Pediatr Neurol. 2018. PMID: 29472023 No abstract available.

Cited by

Hypomyelinating leukodystrophies - unravelling myelin biology.
Wolf NI, Ffrench-Constant C, van der Knaap MS. Wolf NI, et al. Nat Rev Neurol. 2021 Feb;17(2):88-103. doi: 10.1038/s41582-020-00432-1. Epub 2020 Dec 15. Nat Rev Neurol. 2021. PMID: 33324001 Review.
Free sialic acid storage disorder: Progress and promise.
Huizing M, Hackbarth ME, Adams DR, Wasserstein M, Patterson MC, Walkley SU, Gahl WA; FSASD Consortium. Huizing M, et al. Neurosci Lett. 2021 Jun 11;755:135896. doi: 10.1016/j.neulet.2021.135896. Epub 2021 Apr 20. Neurosci Lett. 2021. PMID: 33862140 Free PMC article. Review.
Ataxia in Neurometabolic Disorders.
Kaminiów K, Ryguła I, Paprocka J. Kaminiów K, et al. Metabolites. 2022 Dec 28;13(1):47. doi: 10.3390/metabo13010047. Metabolites. 2022. PMID: 36676973 Free PMC article. Review.
Psychiatric symptoms in Salla disease.
Aulanko I, Rahikkala E, Moilanen J. Aulanko I, et al. Eur Child Adolesc Psychiatry. 2023 Oct;32(10):2043-2047. doi: 10.1007/s00787-022-02031-5. Epub 2022 Jul 7. Eur Child Adolesc Psychiatry. 2023. PMID: 35796883 Free PMC article. Review.
Elevated plasma free sialic acid levels in individuals with reduced glomerular filtration rates.
Fuentes F, Carrillo N, Wilkins KJ, Blake J, Leoyklang P, Gahl WA, Kopp JB, Huizing M. Fuentes F, et al. Kidney360. 2020 Sep 24;1(9):957-961. doi: 10.34067/kid.0002122020. Kidney360. 2020. PMID: 33969317 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease

Affiliations

A New Patient With Intermediate Severe Salla Disease With Hypomyelination: A Literature Review for Salla Disease

Authors

Affiliations

Abstract

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical